Sphingosine kinase type 1 inhibitors and uses thereof

Sphingosine kinase type 1 inhibitors and uses thereof

Provided are inhibitors of sphingosine kinase Type I that are useful in a number of applications, indications and diseases, as well as for monitoring pharmacokinetics and patient management. These compounds are applicable to treating tumors of the central nervous system, such as glioblastoma multifo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zipkin, Robert Elliot, Spiegel, Sarah, Adams, Jeffrey Kroll
Format: Patent
Sprache:eng
Schlagworte:
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Zipkin, Robert Elliot
Spiegel, Sarah
Adams, Jeffrey Kroll
description Provided are inhibitors of sphingosine kinase Type I that are useful in a number of applications, indications and diseases, as well as for monitoring pharmacokinetics and patient management. These compounds are applicable to treating tumors of the central nervous system, such as glioblastoma multiforme (GBM).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9974758B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9974758B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9974758B23</originalsourceid><addsrcrecordid>eNrjZDANLsjIzEvPL87MS1XIzsxLLE5VKKksSFUwVMjMy8hMyizJLypWSMxLUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGhwZaW5ibmphZORsZEKAEAD_ctAA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Sphingosine kinase type 1 inhibitors and uses thereof</title><source>esp@cenet</source><creator>Zipkin, Robert Elliot ; Spiegel, Sarah ; Adams, Jeffrey Kroll</creator><creatorcontrib>Zipkin, Robert Elliot ; Spiegel, Sarah ; Adams, Jeffrey Kroll</creatorcontrib><description>Provided are inhibitors of sphingosine kinase Type I that are useful in a number of applications, indications and diseases, as well as for monitoring pharmacokinetics and patient management. These compounds are applicable to treating tumors of the central nervous system, such as glioblastoma multiforme (GBM).</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180522&amp;DB=EPODOC&amp;CC=US&amp;NR=9974758B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180522&amp;DB=EPODOC&amp;CC=US&amp;NR=9974758B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Zipkin, Robert Elliot</creatorcontrib><creatorcontrib>Spiegel, Sarah</creatorcontrib><creatorcontrib>Adams, Jeffrey Kroll</creatorcontrib><title>Sphingosine kinase type 1 inhibitors and uses thereof</title><description>Provided are inhibitors of sphingosine kinase Type I that are useful in a number of applications, indications and diseases, as well as for monitoring pharmacokinetics and patient management. These compounds are applicable to treating tumors of the central nervous system, such as glioblastoma multiforme (GBM).</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDANLsjIzEvPL87MS1XIzsxLLE5VKKksSFUwVMjMy8hMyizJLypWSMxLUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGhwZaW5ibmphZORsZEKAEAD_ctAA</recordid><startdate>20180522</startdate><enddate>20180522</enddate><creator>Zipkin, Robert Elliot</creator><creator>Spiegel, Sarah</creator><creator>Adams, Jeffrey Kroll</creator><scope>EVB</scope></search><sort><creationdate>20180522</creationdate><title>Sphingosine kinase type 1 inhibitors and uses thereof</title><author>Zipkin, Robert Elliot ; Spiegel, Sarah ; Adams, Jeffrey Kroll</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9974758B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Zipkin, Robert Elliot</creatorcontrib><creatorcontrib>Spiegel, Sarah</creatorcontrib><creatorcontrib>Adams, Jeffrey Kroll</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Zipkin, Robert Elliot</au><au>Spiegel, Sarah</au><au>Adams, Jeffrey Kroll</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Sphingosine kinase type 1 inhibitors and uses thereof</title><date>2018-05-22</date><risdate>2018</risdate><abstract>Provided are inhibitors of sphingosine kinase Type I that are useful in a number of applications, indications and diseases, as well as for monitoring pharmacokinetics and patient management. These compounds are applicable to treating tumors of the central nervous system, such as glioblastoma multiforme (GBM).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9974758B2
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Sphingosine kinase type 1 inhibitors and uses thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T03%3A52%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Zipkin,%20Robert%20Elliot&rft.date=2018-05-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9974758B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true